TIPE2-modified human amnion-derived mesenchymal stem cells promote the efficacy of allogeneic heart transplantation through inducing immune tolerance

BACKGROUND: Immune rejection of heart transplantation has been regarded as the biggest challenge encountered by a patient suffering from end-stage heart disease. The transplantation of human amnion-derived mesenchymal stem cells (hAD-MSCs) has exhibited promising application prospects in organ trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feng, Yao, Guanping, Pan, Sisi, Mao, Xin, Zhao, Xu, Li, Chuntian, Hong, Zheng, Liang, Guiyou, Yu, Limei, Hu, Xuanyi, Peng, Wanfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411184/
https://www.ncbi.nlm.nih.gov/pubmed/34527344
http://dx.doi.org/10.21037/jtd-21-1034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411184/
https://www.ncbi.nlm.nih.gov/pubmed/34527344
http://dx.doi.org/10.21037/jtd-21-1034

Ejemplares similares